NeoTract Announces Independent Analysis in UK Confirming Cost Effectiveness of UroLift® System Treatment for Benign Prostatic Hyperplasia (BPH)
June 8, 2018
WAYNE, PA – June 08, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of...
Read MoreNeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate
May 18, 2018
PLEASANTON, Calif. – May 18, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in the...
Read MoreNeoTract To Unveil New Clinical Data on the UroLift® System at American Urological Association 2018 Meeting
May 16, 2018
PLEASANTON, Calif. - May 16, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the...
Read MoreNeoTract Announces Data from Large Real-World Study of UroLift® System, Confirming Positive Results for Company’s Treatment for Enlarged Prostate
March 20, 2018
PLEASANTON, Calif. – March 19, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in...
Read MoreTeleflex Incorporated Completes Acquisition of Neotract
October 2, 2017
Contact: Jake Elguicze Treasurer and Vice President of Investor Relations 610-948-2836
Read MoreTeleflex Incorporated to Acquire NeoTract
September 5, 2017
FOR IMMEDIATE RELEASE September 5, 2017
Read MoreNeoTract Inc. Announces Cigna Coverage for the UroLift® System for Enlarged Prostate
May 11, 2017
PLEASANTON, Calif.– May 11, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today...
Read MoreNeoTract Inc. Announces Presentations of Multiple Clinical Studies Featuring Five-Year Data from Pivotal Randomized Trial of UroLift® System at American Urological Association 2017 Meeting
May 8, 2017
PLEASANTON, Calif.– May 8, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced...
Read MoreNeoTract Inc. Receives #Gamechanger Award for Innovation
April 17, 2017
PLEASANTON, Calif.– April 13, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, announced...
Read MoreNeoTract’s Minimally Invasive UroLift® System for Enlarged Prostate Now Shown to be Durable Through Five Years: Results from Pivotal L.I.F.T. Randomized Study Presented
March 27, 2017
PLEASANTON, Calif. and LONDON – March 27, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology,...
Read More
